NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,548,064 | -32.5% | 27,883 | +21.1% | 0.30% | -18.9% |
| Q4 2020 | $2,292,000 | +8.5% | 23,027 | -21.3% | 0.38% | -25.1% |
| Q3 2020 | $2,113,000 | +4.7% | 29,254 | -27.8% | 0.50% | +12.3% |
| Q2 2020 | $2,019,000 | +103.7% | 40,493 | +37.6% | 0.45% | +104.6% |
| Q4 2019 | $991,000 | -41.6% | 29,419 | -43.2% | 0.22% | -51.4% |
| Q3 2019 | $1,698,000 | -51.3% | 51,768 | -64.5% | 0.45% | -13.5% |
| Q3 2018 | $3,490,000 | -9.8% | 145,774 | -29.1% | 0.52% | -14.9% |
| Q2 2018 | $3,868,000 | +413.7% | 205,543 | +229.5% | 0.61% | +439.8% |
| Q2 2016 | $753,000 | – | 62,378 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |